High-dose IV Vitamin C May Reduce Mortality and Sepsis in Trauma Patients, Study Suggests
Intravenous vitamin C administered in high doses shows potential to reduce the risk of death and sepsis in patients suffering from trauma. Additionally, it may contribute to shorter hospital stays for these individuals. These findings are based on a review of scientific data published in the journal "BMJ Military Health." The researchers analyzed databases containing studies up to the end of 2025 to assess the impact of vitamin C on trauma patients. The review aimed to consolidate existing evidence on the efficacy of high-dose vitamin C in critical care settings related to trauma. Further details on the specific mechanisms and the extent of the observed benefits are expected from the comprehensive analysis of the selected studies. The study highlights a potential therapeutic avenue for improving outcomes in trauma care.
This review of scientific data suggests a potential benefit of high-dose intravenous vitamin C in mitigating mortality and sepsis risk among trauma patients, alongside a possible reduction in hospitalization duration. The findings, published in "BMJ Military Health," warrant further investigation into the physiological mechanisms driving these effects and their clinical applicability. Evaluating the cost-effectiveness and potential side effects of such a treatment protocol within diverse healthcare systems will be crucial. Future research should focus on randomized controlled trials to establish causality and optimal dosing strategies, considering the complex interplay of factors influencing trauma recovery and the body's response to high-dose vitamin C supplementation.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.